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Abstract Cardiac ATP-sensitive K+ (KATP) channels are pro-
posed to contribute to cardio-protection and ischemic precondi-
tioning. Although mRNAs for all subunits of KATP channels
(Kir6.0 and sulfonylurea receptors SURs) were detected in
hearts, subcellular localization of their proteins and the subunit
combination are not well elucidated. We address these questions
in rat hearts, using anti-peptide antibodies raised against each
subunit. By immunoblot analysis, all of the subunits were de-
tected in microsomal fractions including sarcolemmal mem-
branes, while they were not detected in mitochondrial fractions
at all. Immunoprecipitation and sucrose gradient sedimentation
of the digitonin-solubilized microsomes indicated that Kir6.2
exclusively assembled with SUR2A. The molecular mass of
the Kir6.2^SUR2A complex estimated by sucrose sedimentation
was 1150 kDa, signi¢cantly larger than the calculated value for
(Kir6.2)4^(SUR2A)4, suggesting a potential formation of micel-
lar complex with digitonin but no indication of hybrid channel
formation under the conditions. These ¢ndings provide addition-
al information on the structural and functional relationships of
cardiac KATP channel proteins involving subcellular localization
and roles for cardioprotection and ischemic preconditioning.
5 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
ATP-sensitive potassium (KATP) channels are found in di-
verse cell types, including pancreatic L cells, brain, heart and
skeletal and smooth muscle cells, where they are thought to
couple metabolism with membrane electrical activity [1,2].
KATP channels are abundantly expressed in cardiac tissue.
Cardiac cells are considered to contain two distinct KATP
channels: the classical one in the sarcolemma [3] and the other
in the mitochondrial inner membrane [4]. Sarcolemmal KATP
(sarcKATP) channels were ¢rst proposed to play an important
role in the cardioprotective e¡ect, because potassium channel
openers (KCOs) mimicked the cardioprotection and the KATP
channel blocker glibenclamide abolished the ischemic precon-
ditioning (IPC) [5,6]. However, it has been postulated lately
that mitochondrial KATP (mitoKATP) channels rather than the
sarcKATP channels are important as end e¡ectors and/or trig-
gers of IPC [7,8].
SarcKATP channels are hetero-octameric complexes consist-
ing of four pore-forming subunits Kir6.0 (inwardly rectifying
potassium channel), and four sulfonylurea receptor subunits
(SURs) belonging to the ATP-binding cassette superfamily
[1,2]. Two Kir subunits (Kir6.2 and Kir6.1) and three major
types of SURs (SUR1, SUR2A, and SUR2B) have been
cloned to date [9^13]. It is reported that all subunits of a
KATP channel are expressed in heart at mRNA levels [9,13^
15]. Putative association of Kir6.2 with SUR2A was proposed
for sarcKATP channels, based upon electrophysiological and
pharmacological characterization of channel activity following
co-expression in heterologous expression systems [12,16,17]
and Kir6.2 knockout studies in mice [18], but their features
of subcellular distribution and molecular assembly at the pro-
tein level in hearts are not clear yet. Although Kir6.1 was
proposed to be a component of the mitoKATP channels in
skeletal muscle and liver [19], it is controversial [14,20,21]
and the molecular entity of the mitoKATP channels has not
been determined.
We investigated subcellular distribution and molecular
composition of KATP channels in rat hearts by immunoblot
and immunoprecipitation using several subunit-speci¢c anti-
bodies and by sucrose density gradient sedimentation of the
solubilized channel proteins. We have found that all KATP
subunits are located in microsomal fractions but not in mito-
chondria, and SUR2A forms a heteromultimer with Kir6.2
but not with Kir6.1.
2. Materials and methods
2.1. Antibodies
Rabbit polyclonal antibodies were generated against synthetic pep-
tides corresponding to particular sequences of the rat KATP channel
subunits [9,11^13]: anti-Kir6.1 (near C-terminus), NNSSLMVPK-
VQFMTPEGNQCG; anti-Kir6.2 (near N-terminus), RLAEDPTE-
PRYRTRERRAC; anti-SUR2A (near C-terminus), CNLLQHKN-
GLFSTLVMTNK; and anti-SUR2B (near C-terminus), CSLLA-
QEDGVFASFVRADM. Due to the high sequence homology of the
SUR2B peptide to that of SUR1 (KLLSQKDSVFASFVRADK),
anti-SUR2B was con¢rmed to recognize SUR1 peptide by enzyme-
linked immunosorbent assay. The antibodies were puri¢ed using pro-
tein A^Sepharose columns. Monoclonal antibodies against rabbit car-
diac L-type Ca2þ channel K1 subunit (4D6) and ryanodine receptor 2
(R29) were previously prepared and characterized in our laboratory.
Anti-cytochrome c oxidase subunit IV antibody was obtained from
Molecular Probes Inc. (Eugene, OR, USA).
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2.2. Cell culture and transfection
Plasmid DNAs containing the mouse (Kir6.2+SUR2A) or
(Kir6.1+SUR2B) cDNA were transfected into COS-7 cells using Lipo-
fectAMINE 2000 (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions.
2.3. Membrane preparations
Cardiac microsomes [22] and mitochondrial fractions [23] from
Wistar rats (6 weeks old, male) were prepared as the procedures in
the references indicated above in the presence of ¢ve protease inhib-
itors (0.1 mM phenylmethyl sulfonyl£uoride, 1 Wg/ml leupeptin, 1 Wg/
ml pepstatin A, 10 Wg/ml soybean trypsin inhibitor, and 0.5 mM io-
doacetamide).
2.4. Immunoblot analysis
Proteins were separated on 8.5% SDS^polyacrylamide gel, and elec-
trically transferred to polyvinylidene di£uoride (PVDF) membranes.
The transferred blots were blocked with 2% skim milk in Tris-bu¡ered
saline (TBS, 150 mM NaCl, 20 mM Tris^HCl, pH 7.4) and incubated
for 6 h at 4‡C with the antibodies in TBS, 0.1% Tween 20. After
washing, the blots were reacted with peroxidase-conjugated secondary
antibodies (Zymed Laboratories, South San Francisco, CA, USA) for
60 min at room temperature and developed using enhanced chemilu-
minescent substrates (Pierce, Rockford, IL, USA).
2.5. Immunoprecipitation
Rat cardiac microsomes (2 mg/ml) were solubilized by 1% digitonin
in TBS containing ¢ve protease inhibitors and clari¢ed by centrifuga-
tion at 12 000Ug at 4‡C. The digitonin extracts were diluted with a
four-fold volume of TBS, followed by incubation with 10 Wg of the
antibodies. After the antigen^antibody complex was adsorbed on pro-
tein A^Sepharose gel (20 Wl), the immunocomplex was separated on
8.5% SDS^polyacrylamide gels, and subjected to immunoblot analysis
as described above.
2.6. Sucrose density gradient sedimentation
Digitonin extracts from rat cardiac microsomes were layered onto
5^20% linear sucrose gradients in 0.1% digitonin, TBS, and protease
inhibitors. The gradients were centrifuged at 4‡C in a Beckman SW28
rotor at 122 000Ug for 9 h. Gradients were fractionated from top to
bottom using automatic liquid charger (Advantec, Tokyo, Japan).
Aliquots were subjected to SDS^polyacrylamide gels and immunoblot
analysis. Protein markers used were pentameric IgM (950 kDa), thy-
roglobulin (690 kDa), and catalase (240 kDa). Ryanodine receptor 2
is a homotetramer of 400 kDa subunit (1600 kDa) [24].
3. Results
3.1. Speci¢city of antibodies
We generated antibodies against peptides corresponding to
regions in the N or C terminus of rat KATP subunits ; Kir6.2,
Kir6.1, SUR2A, and SUR2B. We ¢rst tested whether these
antibodies can speci¢cally recognize each subunit using COS-7
cells that transiently express Kir6.2+SUR2A, Kir6.1+SUR2B,
and vector alone. Fig. 1 shows that all antibodies recognize
KATP subunit proteins of the predicted molecular weight in
immunoblots. Using anti-Kir6.2 antibody, only the 38 kDa
band of Kir6.2 was detected in the crude membranes from
COS-7 cells expressing Kir6.2+SUR2A (Fig. 1A, lane 1).
Anti-Kir6.1 antibody speci¢cally recognized the Kir6.1 pro-
tein with apparent molecular mass of 43 kDa (Fig. 1B, lane
2). Anti-SUR2A antibody recognized the SUR2A polypeptide
of 140 kDa (Fig. 1C, lane 1), but not SUR2B. Anti-SUR2B
antibody recognized 150 kDa polypeptides of SUR2B and
possible proteolytic fragments of 100 and 55 kDa (Fig. 1D,
lane 2). These results demonstrate that all antibodies are sub-
unit-speci¢c, and can be used for further immunochemical
studies.
3.2. Subcellular distribution of KATP subunits in native rat
hearts
To determine subcellular localization of KATP subunits, im-
munoblot analysis was carried out for the microsomes and
mitochondrial fractions prepared from rat adult hearts. We
¢rst evaluated the purity of both fractions using antibodies
against marker proteins: cardiac L-type Ca2þ channel K1 sub-
unit for sarcolemmal membranes and cytochrome c oxidase
subunit IV for mitochondria. Fig. 2A clearly shows that both
preparations were well-separated and no cross-contamination
was observed. Using these preparations, Kir6.2 was detected
in microsomes as 40 kDa protein, the same size as Kir6.2
expressed in COS-7 cells, while it was not detected in mito-
chondria (Fig. 2B). Kir6.1 was also identi¢ed as a 43 kDa
band in microsomes, but not in mitochondrial fractions
(Fig. 2C). Anti-SUR2A antibody recognized the 150 kDa
polypeptide in microsomes. The faint 50 kDa band that was
observed both in microsomal and mitochondrial fractions by
the antibody (lanes 1 and 2 in Fig. 2D), was obviously non-
speci¢c staining, because it was stained even in the presence of
competitive antigen peptide (lanes 4 and 5 in Fig. 2D). Anti-
SUR2B detected three polypeptides (150, 100, and 55 kDa) in
microsomes, but not in mitochondrial fractions at all (Fig. 2E).
The 100 and 55 kDa peptides appear to be proteolytic frag-
ments produced from 150 kDa during membrane preparation.
These bands are assigned as SUR2B but can also be assigned
as SUR1, since the sequences of antigen peptide of SUR2B
are highly homologous to the corresponding region of SUR1.
These results indicate that all subunits of KATP cloned to date
are located in microsomal fractions, but none of them exist in
mitochondria.
3.3. Immunoprecipitation experiments
To address the questions whether and what type of Kir and
SUR assemble, we performed immunoprecipitation experi-
ments of solubilized microsomes with the subunit-speci¢c
antibodies (Fig. 3). Anti-SUR2A antibody co-immunoprecipi-
tated SUR2A and Kir6.2. Inversely, anti-Kir6.2 antibody im-
munoprecipitated Kir6.2 and SUR2A, which are the same
subunits as those by anti-SUR2A antibody. By contrast,
anti-Kir6.1 antibody only precipitated Kir6.1 itself, and no
co-immunoprecipitation with either of SUR2A, SUR2B, and
Kir6.2 was observed. These results indicate that Kir6.2 and
Fig. 1. Speci¢city of the generated antibodies by immunoblot analy-
sis. Crude membrane fractions (3.0 Wg) of COS-7 cells transfected
with SUR2A+Kir6.2 (lane 1), SUR2B+Kir6.1 (lane 2), and vector
alone (lane 3) were separated on 8.5% SDS^polyacrylamide gel and
immunoblotted with each antibody. Protein bands were visualized
using enhanced chemiluminescent substrates. The position of each
subunit is indicated by an arrow.
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Kir6.1 are not present in the same channel complex under
these conditions.
3.4. Sucrose density gradient sedimentation
To inspect the subunit assembly in a di¡erent method, we
performed sucrose density gradient sedimentation analysis of
the digitonin-solubilized cardiac microsomes using 5^20% su-
crose density gradients. As shown in Fig. 4A, SUR2A exhib-
ited two peaks: one peak at fractions 3 and 4, and the other
peak at fractions between 8 and 10. However, Kir6.2 was
sedimented as a single peak at fractions between 8 and 10,
where SUR2A and Kir6.2 were co-migrated. In sharp contrast
to Kir6.2, Kir6.1 migrated at fractions near the top of the
gradient (fractions 3 and 4). SUR2B and/or SUR1 were also
detected in the same fractions, suggesting that the SUR2B
and/or SUR1 do not assemble with Kir6.2 under these con-
ditions. These results indicate that all Kir6.2 co-assemble with
SUR2A. The molecular mass of the SUR2A^Kir6.2 complex
is estimated at 1150 kDa by comparison with standard pro-
teins (Fig. 4B).
4. Discussion
We have investigated the subcellular distribution of KATP
channels and their subunit assembly in rat hearts using sub-
unit-speci¢c antibodies and revealed the following: (1) Kir6.1,
Kir6.2, and SUR2A proteins were abundantly expressed, but
SUR2B and/or SUR1 were detected mainly as proteolytic
Fig. 2. Immunoblot analysis of KATP channel subunits in rat hearts. Microsomal (lanes 1 and 4) and mitochondrial fractions (lanes 2 and 5) of
rat hearts, and crude membrane fractions of COS-7 cells transfected with SUR2A+Kir6.2 (lanes 3 and 6 in panels B and D) or SUR2B+Kir6.1
(lanes 3 and 6 in panels C and E) were prepared. Samples (15 Wg each for rat hearts and 3 Wg each for COS-7 cells) were run on 8.5% or 15%
SDS^polyacrylamide gels. Electrophoresed proteins were blotted onto PVDF membranes, and probed with antibodies; anti-cardiac Ca2þ chan-
nel a1 subunit (panel A, left) and anti-cytochrome c subunit IV (panel A, right), anti-Kir6.2 (panel B), anti-Kir6.1 (panel C), anti-SUR2A (pan-
el D), and anti-SUR2B (panel E). Speci¢cally blotted bands are indicated by arrows, and non-speci¢c ones that are con¢rmed by competition
in the presence of antigen peptide (lanes 4^6 in panels B^E) are indicated by an asterisk. Molecular weight (kDa) markers are also shown.
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fragments. (2) All of the subunits were exclusively localized in
the microsomal fractions, but not detected in the mitochon-
drial ones at all. (3) SUR2A tightly associated with Kir6.2,
but not with Kir6.1. Immunoblot data clearly showed that all
of the KATP subunits tested were located in microsome frac-
tions containing sarcolemmal membranes. In contrast, there
was no indication that KATP channels exist in the highly pu-
ri¢ed mitochondrial fractions. Several precedent studies indi-
cated that mitochondrial KATP channels (mitoKATP channels),
rather than sarcolemmal KATP channels, play important roles
for ischemic preconditioning and pharmacological cardiopro-
tection as the target for Kþ channel openers (KCOs). Garlid
et al. reported that the KATP channel from bovine mitochon-
drial inner membranes was puri¢ed and reconstituted [8],
although its primary structure has not been reported yet. Pre-
vious immunohistochemical studies also suggested that Kir6.1
might be a component of the mitoKATP channels in skeletal
muscle [19], but it remained controversial [14,20,21]. Our
present data have brought a conclusion in this issue that
none of the KATP channel subunits cloned so far confer
mitoKATP channels in rat hearts.
The conclusion raises a new question, namely what the
target molecule for KCOs is. Based on our data, the
mitoKATP channel, if it exists, might be composed di¡erently
from the KATP channel subunits cloned so far. Alternatively,
it is more likely that the target molecule is an enzyme related
to mitochondrial energy metabolism, such as succinate dehy-
drogenase that is inhibited by KCOs [25]. Recent reports that
diazoxide directly regulates the mitochondrial oxidation^re-
duction [26] and reduces mitochondrial oxidant stress at the
reoxygenation process [27], supports this possibility.
In the present study of immunoprecipitation and sucrose
sedimentation, we demonstrated that Kir6.2 is tightly and
exclusively associated with SUR2A, even after digitonin sol-
ubilization. Therefore, the cardiac KATP channel is composed
of Kir6.2 and SUR2A proteins at least, but no combination
of Kir6.2 and SUR2B/1 exists. The ¢nding was consistent
with the results obtained by dominant negative gene transfer
[28] and Kir6.2 knockout mice [14,18]. Kir6.2 and SUR2A
form a complex of apparent Mr 1150 kDa estimated by the
sucrose sedimentation. It is of note that the estimated value of
Mr is much larger than the calculated one (760 kDa) for the
octameric complex of (SUR2A)4^(Kir6.1)4. The di¡erence
may be explained by the possibility that the solubilized chan-
nel forms a large micellar complex with detergent digitonin.
Another possibility, that the octameric complex forms a high-
er ordered complex with lactose dehydrogenase like a sarco-
lemmal KATP channel reported recently [29], is not excluded.
In addition to the complex form of Kir6.2^SUR2A, we
observed unassembled SUR2A, Kir6.1 and SUR2B at the
Fig. 3. Immunoprecipitation of the cardiac KATP channel complex.
Immunoprecipitants were separated on 8.5% SDS^polyacrylamide
gel and transferred to PVDF membranes. Digitonin extracts from
microsomes (lane 1) were used as positive controls. Immunoprecipi-
tated samples from the digitonin extracts by anti-SUR2A (lane 2),
anti-Kir6.2 (lane 3), anti-Kir6.1 (lane 4), and control antibody (lane
5) were analyzed. The blots were probed with the indicated antibod-
ies and visualized by enhanced chemiluminescence.
Fig. 4. Sucrose density gradient sedimentation of the KATP channel
complex from rat hearts. A: Digitonin extracts were sedimented on
5^20% sucrose density gradients. Fractionated proteins were ana-
lyzed on 8.5% SDS^polyacrylamide gels, followed by immunoblot-
ting. In blots of SUR2B, three polypeptide bands (150, 100, and
55 kDa, indicated by arrows) were detected similarly as in Fig. 2E.
B: Molecular mass of the SUR2A^Kir6.2 complex (¢lled square)
was estimated by comparing with standard protein markers (open
circle); pentameric IgM (950 kDa), thyroglobulin (690 kDa), cata-
lase (240 kDa), and ryanodine receptor 2 (1600 kDa of homotetra-
mer [24]).
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top of the sucrose gradients. Expression of Kir6.1 protein in
chick heart was reported [30], but which type of SUR subunit
is coupled with Kir6.1 remains unrevealed. The possibility of
octameric complex formation between Kir6.1 and SUR2A in
rat hearts can be excluded by the results of recombinant sub-
units expression [16,17,31] and more recent results using
Kir6.2 knockout mice [18]. In this context, the unassembled
SUR2A is likely a ‘spare subunit’ that is stored in the endo-
plasmic reticulum (ER) until co-tra⁄cking with newly synthe-
sized Kir6.2 to the plasma membrane where they form a func-
tional KATP channel [33], since ER was not eliminated from
the microsomal fractions used here. Stability of the complex
between Kir6.0 and SUR seems sensitive to detergent, because
we could not detect the Kir6.2^SUR2A complex when Triton
X-100 was used (data not shown). Therefore, potential for-
mation of hybrid channels between SUR2A and Kir6.2/6.1
[34^37] might not be excluded by the present results, only if
the Kir6.1 dissociates from the hybrid channel during digito-
nin extraction. It is rather likely that Kir6.1 and SUR2B (or
SUR1) dissociate from their complex during digitonin extrac-
tion (see Fig. 4A). Even in that case, the possibility that the
complex confers a functional cardiac KATP channel may be
negligible, based on the previous reports by co-expression of
the recombinant components [32] and Kir6.1 knockout mice
[14]. These reports also indicated that Kir6.1 and SUR2B
comprise the vascular type KATP channel. Therefore, the pos-
sibility that the SUR2B and Kir6.1 we observed may originate
from vascular tissues in our microsomal fractions is not ex-
cluded. Unfortunately, our antibodies have no ability to im-
munostain the concerned tissues; this issue remains to be
solved. Compared with the stable complex between Kir6.2
and SUR2A after digitonin solubilization, unassembled sub-
units are still needed to investigate whether and what counter-
parts they assemble with.
In summary, we propose that the observed complex of
Kir6.2 with SUR2A, which is possibly octameric and exclu-
sively located in microsomal fractions, is a strong candidate
for the cardiac KATP channel. Further study is required to
clarify the role of Kir6.1 and SUR2B/1 as to what extent.
Acknowledgements: We are grateful to Prof. Yoshihisa Kurachi
(Graduate School of Medicine, Osaka University) for his generous
gifts of mouse Kir6.1, Kir6.2, SUR2A, and SUR2B clones. We also
thank Dr. Kazushige Sakai for discussion. This work was supported
by grants-in-aid from the Ministry of Education, Science, Sports, Cul-
ture, and Technology of Japan (A.K. and H.N.) and a grant from
CREST (Core Research for Evolutionary Science and Technology) of
Japan Science and Technology Corporation (JST) to H.N.
References
[1] Aguilar-Bryan, L., Clement IV, J.P., Gonza¤lez, G., Kunjilwar,
K., Babenko, A. and Bryan, J. (1998) Physiol. Rev. 78, 227^245.
[2] Seino, S. (1999) Annu. Rev. Physiol. 61, 337^362.
[3] Noma, A. (1983) Nature 305, 147^148.
[4] Inoue, I., Nagase, H., Kishi, K. and Higuti, T. (1991) Nature
352, 244^247.
[5] Gross, G.J. and Auchampach, J.A. (1992) Circ. Res. 70, 223^233.
[6] Mizunuma, T., Nithipatikom, K. and Gross, G.J. (1995) Circu-
lation 92, 1236^1245.
[7] Sato, T., Sasaki, N., Seharaseyon, J., O’Rourke, B. and Marba¤n,
E. (2000) Circulation 101, 2418^2423.
[8] Garlid, K.D., Paucek, P., Yarov-Yarovoy, V., Murray, H.N.,
Dabenzio, R.B., D’Alonzo, A.J., Smith, M.A. and Grover, G.J.
(1997) Circ. Res. 81, 1072^1082.
[9] Inagaki, N., Tsuura, Y., Namba, N., Masuda, K., Gonoi, T.,
Horie, M., Seino, Y., Mizuta, M. and Seino, S. (1995) J. Biol.
Chem. 270, 5691^5694.
[10] Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W., Clement IV,
J.P., Boyd III, A.E., Gonza¤lez, G., Herra-Sosa, H., Nguy, K.,
Bryan, J. and Nelson, D.A. (1995) Science 268, 423^426.
[11] Inagaki, N., Gonoi, T., Clement IV, J.P., Namba, N., Inazawa,
J., Gonza¤lez, G., Aguilar-Bryan, L., Seino, S. and Bryan, J.
(1995) Science 270, 1166^1170.
[12] Inagaki, N., Gonoi, T., Clement IV, J.P., Wang, C.Z., Aguilar-
Bryan, L., Bryan, J. and Seino, S. (1996) Neuron 16, 1011^1017.
[13] Isomoto, S., Kondo, C., Yamada, M., Matsumoto, S., Higashi-
guchi, O., Horio, Y., Matsuzawa, Y. and Kurachi, Y. (1996)
J. Biol. Chem. 271, 24321^24324.
[14] Miki, T., Suzuki, M., Shibasaki, T., Uemura, H., Sato, T., Ya-
maguchi, K., Koseki, H., Iwanaga, T., Nakaya, H. and Seino, S.
(2002) Nat. Med. 8, 466^472.
[15] Akao, M., Otani, H., Horie, M., Takano, M., Kuniyasu, A.,
Nakayama, H., Kouchi, I., Murakami, T. and Sasayama, S.
(1997) J. Clin. Invest. 100, 3053^3059.
[16] Babenko, A.P., Gonza¤lez, G., Aguilar-Bryan, L. and Bryan, J.
(1998) Circ. Res. 83, 1132^1143.
[17] Lorenz, E. and Terzic, A. (1999) J. Mol. Cell Cardiol. 31, 425^
434.
[18] Suzuki, M., Li, R.A., Miki, T., Uemura, H., Sakamoto, N.,
Ohmoto-Sekine, Y., Tamagawa, M., Ogura, T., Seino, S., Mar-
ba¤n, E. and Nakaya, H. (2001) Circ. Res. 88, 570^577.
[19] Suzuki, M., Kotake, K., Fujikura, K., Inagaki, N., Suzuki, T.,
Gonoi, T., Seino, S. and Takata, K. (1997) Biochem. Biophys.
Res. Commun. 24, 1693^1697.
[20] Seharaseyon, J., Ohler, A., Sasaki, N., Fraser, H., Sato, T.,
Johns, D.C., O’Rourke, B. and Marba¤n, E. (2000) J. Mol. Cell
Cardiol. 32, 1923^1930.
[21] Thomzig, A., Wenzel, M., Karschin, C., Eaton, M.J., Skatchkov,
S.N., Karschin, A. and Veh, R.W. (2001) Mol. Cell. Neurosci.
18, 671^690.
[22] Jones, L.R., Besch Jr., H.R., Fleming, J.W., McConnaughey,
M.M. and Watanabe, A.M. (1979) J. Biol. Chem. 254, 530^539.
[23] Holmuhamedov, E.L., Jovanovic, S., Dzeja, P.P., Jovanovic, A.
and Terzic, A. (1998) Am. J. Physiol. 275, H1567^1576.
[24] Anderson, K., Lai, F.A., Liu, Q.Y., Rousseau, E., Erickson, H.P.
and Meissner, G. (1989) J. Biol. Chem. 264, 1329^1335.
[25] Schafer, G., Portenhauser, R. and Trolp, R. (1971) Biochem.
Pharmacol. 20, 1271^1280.
[26] Ozcan, C., Bienengraeber, M., Dzeja, P.P. and Terzic, A. (2002)
Am. J. Physiol. Heart Circ. Physiol. 282, H531^539.
[27] Pain, T., Yang, X.M., Critz, S.D., Yue, Y., Nakano, A., Liu,
G.S., Heusch, G., Cohen, M.V. and Downey, J.M. (2000) Circ.
Res. 87, 460^466.
[28] Seharaseyon, J., Sasaki, N., Ohler, A., Sato, T., Fraser, H.,
Johns, D.C., O’Rourke, B. and Marba¤n, E. (2000) J. Biol.
Chem. 275, 17561^17565.
[29] Crawford, R.M., Budas, G.R., Jovanovic, S., Ranki, H.J., Wil-
son, T.J., Davies, A.M. and Jovanovic, A. (2002) EMBO J. 21,
3936^3948.
[30] Lu, C. and Halvorsen, S.W. (1997) FEBS Lett. 412, 121^125.
[31] Okuyama, Y., Yamada, M., Kondo, C., Satoh, E., Isomoto, S.,
Shindo, T., Horio, Y., Kitakaze, M., Hori, M. and Kurachi, Y.
(1998) P£uegers Arch. 435, 595^603.
[32] Russ, U., Hambrock, A., Artunc, F., Lo¥er-Walz, C., Horio, Y.,
Kurachi, Y. and Quast, U. (1999) Mol. Pharmacol. 56, 955^961.
[33] Zerangue, N., Schwappach, B., Jan, Y.N. and Jan, L.Y. (1999)
Neuron 22, 537^548.
[34] Kono, Y., Horie, M., Takano, M., Otani, H., Xie, L.H., Akao,
M., Tsuji, K. and Sasayama, S. (2000) P£uegers Arch. 440, 692^
698.
[35] Pountney, D.J., Sun, Z.Q., Porter, L.M., Nitabach, M.N., Na-
kamura, T.Y., Holmes, D., Rosner, E., Kaneko, M., Manaris, T.,
Holmes, T.C. and Coetzee, W.A. (2001) J. Mol. Cell Cardiol. 33,
1541^1546.
[36] Babenko, A.P. and Bryan, J. (2001) J. Biol. Chem. 276, 49083^
49092.
[37] Cui, Y., Giblin, J.P., Clapp, L.H. and Tinker, A. (2002) Proc.
Natl. Acad. Sci. USA 98, 729^734.
FEBS 27624 11-9-03
A. Kuniyasu et al./FEBS Letters 552 (2003) 259^263 263
